Status:
COMPLETED
Impact of Pharmacist-led Cognitive Behavioral Intervention on Adherence and Quality of Life of Epileptic Patients
Lead Sponsor:
Hamdard University
Conditions:
Epilepsy
Eligibility:
All Genders
15-70 years
Phase:
NA
Brief Summary
The purpose of this interventional study is to assess the impact of pharmacist-led cognitive behavioral intervention in epileptic patients. The main questions are: 1. If pharmacist-led cognitive beha...
Detailed Description
The purpose of the study is to investigate whether incorporation of pharmacist-led cognitive behavioral therapy (CBT) to the treatment of epileptic patients can result in better adherence to anti epil...
Eligibility Criteria
Inclusion
- Patients with confirmed diagnosis.
- Patients treated for epilepsy with at least one anti epileptic drug, subjects willing to participate in the study with or without other severe co-morbidities were included in the study.
Exclusion
- Pregnant female patients.
- Patients who provide incomplete information
- Patients with any terminal disease e.g., end stage renal disease
- Patients not willing to participate were excluded from the study.
Key Trial Info
Start Date :
September 22 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 15 2024
Estimated Enrollment :
385 Patients enrolled
Trial Details
Trial ID
NCT06034353
Start Date
September 22 2023
End Date
July 15 2024
Last Update
January 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shifa International Hospital
Islamabad, Pakistan